In this educational initiative, expert faculty address barriers to achieving safe and effective moderate to deep neuromuscular blockade and reversal in the perioperative setting. Patient cases are used to provide real world patient management strategies for addressing issues related to neuromuscular blockade and reversal.
In this interprofessional activity, expert faculty will use patient cases to discuss the clinical effects of neuromuscular blocking and reversal agents, including key components of NMB and reversal during the intraoperative phase of care and neuromuscular monitoring. Criteria for use, dosing of specific reversal agents and assessment of risk factors and mitigation of post-operative complications will also be discussed.
April 8, 2021
12:00 - 1:00 p.m. ET
The content for this activity is based on questions and comments from participants in the first educational activity on this topic.
Expert faculty discuss current challenges and overcoming barriers to achieve safe and effective moderate to deep neuromuscular blockade and reversal.
Expert faculty reflect on overcoming barriers to achieve safe and effective moderate to deep neuromuscular blockade and reversal.